GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias)
- PMID: 21247734
- DOI: 10.1016/j.jclinepi.2010.07.017
GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias)
Abstract
In the GRADE approach, randomized trials start as high-quality evidence and observational studies as low-quality evidence, but both can be rated down if most of the relevant evidence comes from studies that suffer from a high risk of bias. Well-established limitations of randomized trials include failure to conceal allocation, failure to blind, loss to follow-up, and failure to appropriately consider the intention-to-treat principle. More recently recognized limitations include stopping early for apparent benefit and selective reporting of outcomes according to the results. Key limitations of observational studies include use of inappropriate controls and failure to adequately adjust for prognostic imbalance. Risk of bias may vary across outcomes (e.g., loss to follow-up may be far less for all-cause mortality than for quality of life), a consideration that many systematic reviews ignore. In deciding whether to rate down for risk of bias--whether for randomized trials or observational studies--authors should not take an approach that averages across studies. Rather, for any individual outcome, when there are some studies with a high risk, and some with a low risk of bias, they should consider including only the studies with a lower risk of bias.
Copyright © 2011 Elsevier Inc. All rights reserved.
Similar articles
-
[GRADE guidelines: 4. Rating the quality of evidence - limitations of clinical trials (risk of bias)].Z Evid Fortbild Qual Gesundhwes. 2012;106(6):457-69. doi: 10.1016/j.zefq.2012.06.014. Epub 2012 Jul 6. Z Evid Fortbild Qual Gesundhwes. 2012. PMID: 22857734 German.
-
Synthesis, grading, and presentation of evidence in guidelines: article 7 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.Proc Am Thorac Soc. 2012 Dec;9(5):256-61. doi: 10.1513/pats.201208-060ST. Proc Am Thorac Soc. 2012. PMID: 23256168 Review.
-
GRADE guidelines: 5. Rating the quality of evidence--publication bias.J Clin Epidemiol. 2011 Dec;64(12):1277-82. doi: 10.1016/j.jclinepi.2011.01.011. Epub 2011 Jul 30. J Clin Epidemiol. 2011. PMID: 21802904
-
Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies.Pain Physician. 2009 Sep-Oct;12(5):819-50. Pain Physician. 2009. PMID: 19787009
-
GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes.J Clin Epidemiol. 2013 Feb;66(2):158-72. doi: 10.1016/j.jclinepi.2012.01.012. Epub 2012 May 18. J Clin Epidemiol. 2013. PMID: 22609141 Review.
Cited by
-
Comparative effectiveness of treatments for recurrent Clostridioides difficile infection: a network meta-analysis of randomized controlled trials.Front Pharmacol. 2024 Oct 17;15:1430724. doi: 10.3389/fphar.2024.1430724. eCollection 2024. Front Pharmacol. 2024. PMID: 39484168 Free PMC article.
-
Surgical outcomes of neoadjuvant endocrine treatment in early breast cancer: meta-analysis.BJS Open. 2024 Sep 3;8(5):zrae100. doi: 10.1093/bjsopen/zrae100. BJS Open. 2024. PMID: 39423044 Free PMC article.
-
Adverse pregnancy outcomes and multiple cancers risk in both mother and offspring: an umbrella review of systematic reviews with meta-analyses of observational studies.BMC Med. 2024 Oct 11;22(1):454. doi: 10.1186/s12916-024-03680-w. BMC Med. 2024. PMID: 39394137 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
